Waubant E, Stuve O. 2002. Suspected mechanisms involved in multiple sclerosis and putative role of hepatitis B vaccine in multiple sclerosis. Commissioned Background Paper for IOM Immunization Safety Review Committee.

Weed DL, Hursting SD. 1998. Biologic plausibility in causal inference: Current method and practice. Am J Epidemiol 147(5):415–25.

Wise RP, Kiminyo KP, Salive ME. 1997. Hair loss after routine immunizations. JAMA 278(14):1176–8.

Wucherpfennig KW. 2001. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 108(8):1097–104.

Yusuf HR, Daniels D, Smith P, Coronado V, Rodewald L. 2000. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series. JAMA 284(8):978–83.


Zinkemagel RM. 2001. Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med 345(18):1331–5.

Zipp F, Weil JG, Einhaupl KM. 1999. No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 5(9):964–5.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement